{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:24:34Z","timestamp":1791044674007,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T00:00:00Z","timestamp":1346889600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/2162-3619-1-26","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T18:14:03Z","timestamp":1346955243000},"source":"Crossref","is-referenced-by-count":20,"title":["Eculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation"],"prefix":"10.1186","volume":"1","author":[{"given":"Andr\u00e9s","family":"Brodsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavio","family":"Mazzocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gus","family":"Khursigara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suneil","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Volpacchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,6]]},"reference":[{"key":"23_CR1","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1055\/s-0031-1273095","volume":"37","author":"IC Weitz","year":"2011","unstructured":"Weitz IC: Thrombosis in patients with paroxysmal nocturnal hemoglobinuria. Semin Thromb Hemost 2011, 37: 315\u2013321. 10.1055\/s-0031-1273095","journal-title":"Semin Thromb Hemost"},{"key":"23_CR2","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","volume":"333","author":"P Hillmen","year":"1995","unstructured":"Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV: Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995, 333: 1253\u20131258. 10.1056\/NEJM199511093331904","journal-title":"N Engl J Med"},{"key":"23_CR3","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","volume":"110","author":"P Hillmen","year":"2007","unstructured":"Hillmen P, Muus P, D\u00fchrsen U, Risitano AM, Schubert J, Luzzatto L, Schrezenmeier H, Szer J, Brodsky RA, Hill A, Soci\u00e9 G, Bessler M, Rollins SA, Bell L, Rother RP, Young NS: Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 2007, 110: 4123\u20134128. 10.1182\/blood-2007-06-095646","journal-title":"Blood"},{"key":"23_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0140-6736(95)12360-1","volume":"348","author":"G Soci\u00e9","year":"1996","unstructured":"Soci\u00e9 G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, Heudier P, Rochant H, Cahn JY, Gluckman E: Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet 1996, 348: 573\u2013577. 10.1016\/S0140-6736(95)12360-1","journal-title":"Lancet"},{"key":"23_CR5","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","volume":"112","author":"RP de Latour","year":"2008","unstructured":"de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn JY, Soci\u00e9 G: French Society of Hematology; French Association of Young Hematologists: Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 2008, 112: 3099\u20133106. 10.1182\/blood-2008-01-133918","journal-title":"Blood"},{"key":"23_CR6","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, Mitchell LD, Cohen DR, Gregory WM, Hillmen P: Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 2011, 117: 6786\u20136792. 10.1182\/blood-2011-02-333997","journal-title":"Blood"},{"key":"23_CR7","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1002\/hep.21354","volume":"44","author":"A Plessier","year":"2006","unstructured":"Plessier A, Sibert A, Consigny Y, Hakime A, Zappa M, Denninger MH, Condat B, Farges O, Chagneau C, de Ledinghen V, Francoz C, Sauvanet A, Vilgrain V, Belghiti J, Durand F, Valla D: Aiming at minimal invasiveness as a therapeutic strategy for Budd-Chiari syndrome. Hepatology 2006, 44: 1308\u20131316. 10.1002\/hep.21354","journal-title":"Hepatology"},{"key":"23_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/01.md.0000126763.68170.46","volume":"83","author":"J Nishimura","year":"2004","unstructured":"Nishimura J, Kanakura Y, Ware RE, Shichishima T, Nakakuma H, Ninomiya H, Decastro CM, Hall S, Kanamaru A, Sullivan KM, Mizoguchi H, Omine M, Kinoshita T, Rosse WF: Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore) 2004, 83: 193\u2013207. 10.1097\/01.md.0000126763.68170.46","journal-title":"Medicine (Baltimore)"},{"key":"23_CR9","volume-title":"Haematologica","author":"RP de Latour","year":"2012","unstructured":"de Latour RP, Schrezenmeier H, Bacigalupo A, Blaise D, de Souza CA, Vigouroux S, Willemze R, Terriou L, Tichelli A, Mohty M, de Guibert S, Marsh JCW, Passweg J, Mary JY, Socie G: Allogeneic hematopoietic stem cell transplantation in paroxysmal nocturnal hemoglobinuria. Haematologica 2012. Epub ahead of print"},{"key":"23_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1002\/lt.21714","volume":"15","author":"AL Singer","year":"2009","unstructured":"Singer AL, Locke JE, Stewart ZA, Lonze BE, Hamilton JP, Scudiere JR, Anders RA, Rother RP, Brodsky RA, Cameron AM: Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab. Liver Transpl 2009, 15: 540\u2013543. 10.1002\/lt.21714","journal-title":"Liver Transpl"},{"key":"23_CR11","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, Brodsky RA, Soci\u00e9 G, Muus P, R\u00f6th A, Szer J, Elebute MO, Nakamura R, Browne P, Risitano AM, Hill A, Schrezenmeier H, Fu CL, Maciejewski J, Rollins SA, Mojcik CF, Rother RP, Luzzatto L: The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 2006, 355: 1233\u20131243. 10.1056\/NEJMoa061648","journal-title":"N Engl J Med"},{"key":"23_CR12","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","volume":"111","author":"RA Brodsky","year":"2008","unstructured":"Brodsky RA, Young NS, Antonioli E, Risitano AM, Schrezenmeier H, Schubert J, Gaya A, Coyle L, de Castro C, Fu CL, Maciejewski JP, Bessler M, Kroon HA, Rother RP, Hillmen P: Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 2008, 111: 1840\u20131847. 10.1182\/blood-2007-06-094136","journal-title":"Blood"},{"issue":"Suppl 2","key":"23_CR13","first-page":"105","volume":"96","author":"P Hillmen","year":"2011","unstructured":"Hillmen P, Risitano A, Schrezenmeier H, Schubert J, Maciejewski J, D\u00fchrsen U, Muus P, Szer J, de Castro C, Soci\u00e9 G, Brodsky A: Long-term outcomes in patients with paroxysmal nocturnal hemoglobinuria (PNH) with sustained eculizumab treatment [abstract]. Haematologica 2011,96(Suppl 2):105.","journal-title":"Haematologica"},{"key":"23_CR14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/ajh.21757","volume":"85","author":"P Hillmen","year":"2010","unstructured":"Hillmen P, Elebute M, Kelly R, Urbano-Ispizua A, Hill A, Rother RP, Khursigara G, Fu CL, Omine M, Browne P, Rosse W: Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria. Am J Hematol 2010, 85: 553\u2013559. 10.1002\/ajh.21757","journal-title":"Am J Hematol"},{"key":"23_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1365-2141.2010.08096.x","volume":"149","author":"A Hill","year":"2010","unstructured":"Hill A, Rother RP, Wang X, Morris SM, Quinn-Senger K, Kelly R, Richards SJ, Bessler M, Bell L, Hillmen P, Gladwin MT: Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 2010, 149: 414\u2013425. 10.1111\/j.1365-2141.2010.08096.x","journal-title":"Br J Haematol"},{"key":"23_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.2353\/ajpath.2007.070166","volume":"171","author":"MM Markiewski","year":"2007","unstructured":"Markiewski MM, Lambris JD: The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am J Pathol 2007, 171: 715\u2013727. 10.2353\/ajpath.2007.070166","journal-title":"Am J Pathol"},{"key":"23_CR17","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","volume":"9","author":"PF Zipfel","year":"2009","unstructured":"Zipfel PF, Skerka C: Complement regulators and inhibitory proteins. Nat Rev Immunol 2009, 9: 729\u2013740.","journal-title":"Nat Rev Immunol"},{"key":"23_CR18","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","volume":"293","author":"RP Rother","year":"2005","unstructured":"Rother RP, Bell L, Hillmen P, Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005, 293: 1653\u20131662. 10.1001\/jama.293.13.1653","journal-title":"JAMA"},{"key":"23_CR19","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1182\/blood-2009-06-204669","volume":"114","author":"G Soci\u00e9","year":"2009","unstructured":"Soci\u00e9 G, Muus P, Schrezenmeier H, Hochsmann B, Maciejewski JP, Weitz IC, Hill A, Bessler M, Risitano AM: Terminal complement inhibitor Eculizumab improves complement-mediated platelet consumption and thrombocytopenia in patients with paroxysmal nocturnal hemoglobinuria (PNH) [abstract]. Blood 2009, 114: 4030.","journal-title":"Blood"},{"key":"23_CR20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.jhep.2009.06.019","volume":"51","author":"J Hoekstra","year":"2009","unstructured":"Hoekstra J, Leebeek FW, Plessier A, Raffa S, Darwish Murad S, Heller J, Hadengue A, Chagneau C, Elias E, Primignani M, Garcia-Pagan JC, Valla DC, Janssen HL: European Network for Vascular Disorders of the Liver: Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study. J Hepatol 2009, 51: 696\u2013706. 10.1016\/j.jhep.2009.06.019","journal-title":"J Hepatol"}],"container-title":["Experimental Hematology & Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2162-3619-1-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2162-3619-1-26\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2162-3619-1-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T06:17:29Z","timestamp":1548137849000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/2162-3619-1-26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,6]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["23"],"URL":"https:\/\/doi.org\/10.1186\/2162-3619-1-26","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,6]]},"article-number":"26"}}